David McGirr
Directeur/Membre du Conseil chez INSMED INCORPORATED
Fortune : 3 M $ au 30/04/2024
Profil
David W.
J.
McGirr is an Independent Director who currently holds positions at Insmed, Inc., Rhythm Pharmaceuticals, Inc., and X4 Pharmaceuticals, Inc. He previously served as the Chief Executive Officer of Cubist Pharmaceuticals LLC, President & Chief Executive Officer of GAB Robins North America, Inc., and President, Chief Operating Officer & Director of Hippo, Inc. He also held various director positions at LifeCell Corp., Sorrento Tech, Inc., Arsanis, Inc., Menlo Therapeutics, Inc., Relypsa, Inc., and Roka Bioscience, Inc. McGirr received his undergraduate degree from the University of Glasgow and his MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
INSMED INCORPORATED
0,07% | 13/05/2024 | 98 915 ( 0,07% ) | 2 M $ | 30/04/2024 |
X4 PHARMACEUTICALS, INC.
0,03% | 31/03/2024 | 51 667 ( 0,03% ) | 58 384 $ | 30/04/2024 |
| 22/04/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de David McGirr
| Sociétés | Poste | Début |
|---|---|---|
| INSMED INCORPORATED | Directeur/Membre du Conseil | 30/10/2013 |
| RHYTHM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/11/2015 |
| X4 PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/09/2017 |
Anciens postes connus de David McGirr
| Sociétés | Poste | Fin |
|---|---|---|
| VYNE THERAPEUTICS INC. | Directeur/Membre du Conseil | 09/03/2020 |
| SORRENTO TECH INC | Directeur/Membre du Conseil | 01/01/2018 |
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Directeur/Membre du Conseil | 01/01/2018 |
| RELYPSA INC | Directeur/Membre du Conseil | 01/09/2016 |
| CUBIST PHARMACEUTICALS INC | Directeur Général | 01/06/2014 |
Formation de David McGirr
| University of Glasgow | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INSMED INCORPORATED | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| X4 PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 11 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
GAB Robins North America, Inc.
 GAB Robins North America, Inc. Insurance Brokers/ServicesFinance GAB Robins North America, Inc. provides insurance claim services. It offers administration services to property & casualty insurance companies and self-insured organizations. The firm also offers third-party insurance fund administration and other insurance related services in 52 countries around the world. GAB Robins North America was founded in 1932 and is headquartered in Parsippany, NJ. | Finance |
Hippo, Inc.
 Hippo, Inc. Internet RetailRetail Trade Hippo, Inc. is an online retailer that specializes in selling bellman carts and waste receptacles. | Retail Trade |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Sorrento Tech, Inc.
 Sorrento Tech, Inc. Medical SpecialtiesHealth Technology Sorrento Tech, Inc., also known as Roka Bio Science, is a private company that specializes in food safety technology. The company is based in Warren, NJ and has subsidiaries in the United States. The company's core technology is the Roka pathogen detection assays, which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to deliver a fully automated, single-protocol assay with reduced enrichment times and superior sensitivity. The company's products include the Atlas® system and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bio Science provides solutions for the beef, dairy, pet food, poultry, produce, ready-to-eat foods, spices and ingredients, and environmental testing industries. Roka Bio Science was founded in 2009 by Paul G. Thomas. | Health Technology |
| S.G. Warburg & Co., Inc. | Finance |
Arsanis, Inc.
 Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Menlo Therapeutics, Inc.
 Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
S.G. Warburg Group Plc
 S.G. Warburg Group Plc Investment Banks/BrokersFinance S.G. Warburg Group Plc provides investment banking services. The company is focusing on mergers and acquisitions. It was founded in 1934 and is headquartered in London, the United Kingdom. | Finance |
Roka Bioscience, Inc.
Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Health Technology |